COVAXIN Vaccine Approved for Children in India
CDSCO has said that Bharat Biotech’s Covaxin is safe to use on children and will help protect them against the Coronavirus.
Bharat Biotech submitted data from clinical trials in the 2 - 18 age group for Covaxin to CDSCO (Central Drugs Standard Control Organisation). An expert panel within the organisation studied the data, and said that it is safe to use on children and will help protect them against the Coronavirus. That final approval - viewed as a formality - will be given by the Drug Controller General of India (DCGI).
Zydus Cadila's three-dose was the 1st vaccine which was approved for children and adults above the age of 12. Now Covaxin will be the second vaccine cleared for use on kids in India. The 3rd vaccine for children could be Serum Institute of India’s Novavax, for which the DCGI last month cleared testing on children between seven and 11 years. The 4th could be Biological E's - Corbevax which has been allowed to be tested on children above the age of five.
